Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Apr;6(4):e238-e250.
doi: 10.1016/S2589-7500(23)00267-4.

Machine learning-enabled maternal risk assessment for women with pre-eclampsia (the PIERS-ML model): a modelling study

Collaborators, Affiliations

Machine learning-enabled maternal risk assessment for women with pre-eclampsia (the PIERS-ML model): a modelling study

Tünde Montgomery-Csobán et al. Lancet Digit Health. 2024 Apr.

Abstract

Background: Affecting 2-4% of pregnancies, pre-eclampsia is a leading cause of maternal death and morbidity worldwide. Using routinely available data, we aimed to develop and validate a novel machine learning-based and clinical setting-responsive time-of-disease model to rule out and rule in adverse maternal outcomes in women presenting with pre-eclampsia.

Methods: We used health system, demographic, and clinical data from the day of first assessment with pre-eclampsia to predict a Delphi-derived composite outcome of maternal mortality or severe morbidity within 2 days. Machine learning methods, multiple imputation, and ten-fold cross-validation were used to fit models on a development dataset (75% of combined published data of 8843 patients from 11 low-income, middle-income, and high-income countries). Validation was undertaken on the unseen 25%, and an additional external validation was performed in 2901 inpatient women admitted with pre-eclampsia to two hospitals in south-east England. Predictive risk accuracy was determined by area-under-the-receiver-operator characteristic (AUROC), and risk categories were data-driven and defined by negative (-LR) and positive (+LR) likelihood ratios.

Findings: Of 8843 participants, 590 (6·7%) developed the composite adverse maternal outcome within 2 days, 813 (9·2%) within 7 days, and 1083 (12·2%) at any time. An 18-variable random forest-based prediction model, PIERS-ML, was accurate (AUROC 0·80 [95% CI 0·76-0·84] vs the currently used logistic regression model, fullPIERS: AUROC 0·68 [0·63-0·74]) and categorised women into very low risk (-LR <0·1; eight [0·7%] of 1103 women), low risk (-LR 0·1 to 0·2; 321 [29·1%] women), moderate risk (-LR >0·2 and +LR <5·0; 676 [61·3%] women), high risk (+LR 5·0 to 10·0, 87 [7·9%] women), and very high risk (+LR >10·0; 11 [1·0%] women). Adverse maternal event rates were 0% for very low risk, 2% for low risk, 5% for moderate risk, 26% for high risk, and 91% for very high risk within 48 h. The 2901 women in the external validation dataset were accurately classified as being at very low risk (0% with outcomes), low risk (1%), moderate risk (4%), high risk (33%), or very high risk (67%).

Interpretation: The PIERS-ML model improves identification of women with pre-eclampsia who are at lowest and greatest risk of severe adverse maternal outcomes within 2 days of assessment, and can support provision of accurate guidance to women, their families, and their maternity care providers.

Funding: University of Strathclyde Diversity in Data Linkage Centre for Doctoral Training, the Fetal Medicine Foundation, The Canadian Institutes of Health Research, and the Bill & Melinda Gates Foundation.

PubMed Disclaimer

Conflict of interest statement

Declaration of interests TM-C, KK, PM, SJEB, LAM, and PvD acknowledge that the intellectual property related to the PIERS-ML model has been registered, and that the inventors have no financial benefit from the use of the model based on the transfer. TM-C was funded by the University of Strathclyde, through the STRADDLE (University of Strathclyde Diversity in Data Linkage) Centre for Doctoral Training. All other authors declare no competing interests.

Figures

Figure 1
Figure 1
Shapley values for the PIERS-ML variables in a single random forest on the corresponding development dataset Shapley values represent the feature value's contribution to the individual's predicted probability. Positive Shapley values increase the predicted probability, negative values decrease the predicted probability, and values of zero show no change to the predicted probability. EDD=expected date of delivery. GDP=gross domestic product. SpO2=oxygen saturation by pulse oximetry.
Figure 2
Figure 2
PIERS-ML variables ranked by importance within the random forest model based on Gini index, compared with the least important variable (National MMR) Random Forests enable examination of feature importances, which is the mean of the amount the Gini Index (or node impurity) decreases by in each tree at the split that uses the feature. The more the Gini Index decreases for a feature, the more important it is. This figure rates the features from 0–100, with 100 being the most important. EDD=expected date of delivery. GDP=gross domestic product. SpO2=oxygen saturation by pulse oximetry.
Figure 3
Figure 3
Calibration plot for the PIERS-ML model Predictions on the validation and testing datasets, in increasing order, were binned together into ten groups of 221 predictions. Event rates (observed risk) were calculated along with confidence intervals and plotted against the mean predicted probability per group to create the dot and whisker plot. Smooth lines were plotted using the individual predicted probabilities and yes and no outcomes, with Linear (red) and Loess (blue) methods. Cox calibration intercept and slope, Brier score, and Spiegelhalter Z scores were calculated.
Figure 4
Figure 4
PIERS-ML area under receiver-operator characteristic for adverse maternal outcomes within 2 days of initial assessment using data within 1 day of initial assessment and before the occurrence of any outcome Area-under-the receiver-operator characteristic of 0·78 (95% CI 0·73–0·82).
Figure 5
Figure 5
Precision-recall plot for the PIERS-ML model

References

    1. Magee LA, Brown MA, Hall DR, et al. The 2021 International Society for the Study of Hypertension in Pregnancy classification, diagnosis & management recommendations for international practice. Pregnancy Hypertens. 2022;27:148–169. - PubMed
    1. Magee LA, Nicolaides KH, von Dadelszen P. Preeclampsia. N Engl J Med. 2022;386:1817–1832. - PubMed
    1. Heitkamp A, Meulenbroek A, van Roosmalen J, et al. Maternal mortality: near-miss events in middle-income countries, a systematic review. Bull World Health Organ. 2021;99:693–707F. - PMC - PubMed
    1. Magee LA, Sharma S, Nathan HL, et al. The incidence of pregnancy hypertension in India, Pakistan, Mozambique, and Nigeria: a prospective population-level analysis. PLoS Med. 2019;16 - PMC - PubMed
    1. Payne BA, Hutcheon JA, Ansermino JM, et al. A risk prediction model for the assessment and triage of women with hypertensive disorders of pregnancy in low-resourced settings: the miniPIERS (Pre-eclampsia Integrated Estimate of RiSk) multi-country prospective cohort study. PLoS Med. 2014;11 - PMC - PubMed

Publication types